Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

409

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

February 29, 2012

Conditions
Alzheimer's DiseaseCentral Nervous System DiseasesCognition
Interventions
DRUG

EVP-6124

DRUG

Placebo

Trial Locations (54)

10523

Advanced Bio Behavioral Sciences Inc., Elmsford

11000

Clinical site 1, Belgrade

Clinical Site 2, Belgrade

11214

Brooklyn Medical Institute, Brooklyn

11235

Social Psychiatry Research Institute, Brooklyn

14620

University of Rochester Medical Center at MCH, Rochester

18000

Niš

21005

Vinnytsia

23185

The Center for Excellence in Aging and Geriatric Health, Williamsburg

31909

Columbus Research and Wellness Institute, Columbus

32806

Compass Research, LLC, Orlando

33009

MD Clinical, Hallandale

33166

Galiz Research, Miami Springs

33445

Brain Matters Research, Delray Beach

34000

Kragujevac

34471

Renstar Medical Research, Ocala

34601

Meridien Research, Brooksville

65006

Odesa

75231

FutureSearch Trials of Dallas, L.P., Dallas

76309

Grayline Clinical Drug Trials, Wichita Falls

83037

Donets'k

85050

HOPE Research Institute, Phoenix

91710

Catalina Research Institute, Chino

92626

ATP Clinical Research, Costa Mesa

92868

University of California, Irvine, Orange

95006

Simferopol

95405

Radiant Research, Santa Rosa

97210

Summit Research Network, Portland

115552

Clinical Site 1, Moscow

190005

Clinical Site 1, Saint Petersburg

190103

Clinical Site 2, Saint Petersburg

194175

Clinical Site 3, Saint Petersburg

394052

Voronezh

410060

Saratov

410154

Oradea

420064

Kazan'

490005

Dnipro

700282

Iași

06851

Research Center for Clinical Studies, Inc., Norwalk

06708

Chase Medical Research, LLC, Waterbury

08540

Princeton Medical Institute, Princeton

08755

Memory Enhancement Center of NJ, Toms River

05201

The Memory Clinic, Bennington

Unknown

Clinical Site 1, Bucharest

Clinical Site 2, Bucharest

Clinical Site 3, Bucharest

Clinical Site 4, Bucharest

Clinical Site 5, Bucharest

Târgu Mureş

Clinical Site 2, Moscow

Clinical Site 4, Saint Petersburg

Yekaterinburg

04080

(1), Kyiv

(2), Kyiv

Sponsors
All Listed Sponsors
collaborator

INC Research Limited

INDUSTRY

lead

FORUM Pharmaceuticals Inc

INDUSTRY